Cargando…
Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway
BACKGROUND: CD300A, a type I transmembrane glycoprotein receptor, plays an important role in immune response. Recent studies have reported that CD300A is involved in the development of hematological malignancies. PURPOSE: The objective of this study was to investigate the role of CD300A in the progr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290927/ https://www.ncbi.nlm.nih.gov/pubmed/30573974 http://dx.doi.org/10.2147/OTT.S185521 |